Short Interest in Enzolytics, Inc. (OTCMKTS:ENZC) Expands By 28,550.0%

Enzolytics, Inc. (OTCMKTS:ENZC) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 57,300 shares, an increase of 28,550.0% from the December 31st total of 200 shares. Based on an average daily volume of 21,887,900 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Trading Down 11.1 %

Shares of ENZC stock opened at $0.00 on Wednesday. Enzolytics has a 52 week low of $0.00 and a 52 week high of $0.02.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.